{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"neuronal-ceroid-lipofuscinosis-10","columns":[{"countQualifier":"Onset group unspecified","gene":"CTSD","key":"population-f84c7caf535a7be3dae7","label":"CLN10","mondoId":"MONDO:0012414","onsetQualifier":null,"originColumnKey":"MONDO:0012414","originalViews":[{"key":"MONDO:0012414","label":"CLN10","scopeLabel":"Genetic form","sourceScope":null}],"recordKeys":["0a41ab21ec49151348a41d69ed07aaa57b701ec0c1d494f6495c8dcfbfc19126","0c4410c90ce4fa0b2b0a35c29463863e1b601f47468349ea3bda02df58a95f3a","310b501f770675d41a3cd7bbe4b36ee539d6115926db0a1896ef834d27625b04","313421fa839df22dae3779446458bc366d684796c2f2e160ffff54a810d42ab2","3cbfc0db37c239d51cc68ec6006dbcb714eb9e1311b8428b4ce9f53c2a1a1160","476330ebf193412bb6189c2b2ed80c2bdcb5a03b5c12f21c6b2ee1041f91b20f","4b6645fb6b152c5175364345486e48b5750e462f419fc80318996ea91b085f04","52ddbd11d64b9e1176e5e25564c75cc0ee12693b08701cbb8b8e9ce353cd48ed","530b64596630920edb7ad1ff140bdc71dcf9125b4f7ae8095b3a1128c5ef2ee5","60105fdae3863de8e41a8be02df52a3fb928d3d2f462492bd28700c00b50f6d5","6686e6431761ed2e0ca7eadfd03b08a12cacf6784e7c626bc81c71b98477d7f5","70164ca550720bfde8067c77a6f875f29c41d509c40fe098a906e28f260b3b55","829e3794ae178617929bce4af09766aaa099d50f20e1da7651f7222f1e43659e","8475c4a36341652035a16ef41e8d09803459c9eb4e9fea843886eedfd8504126","986906ad549af6681c8bf736c4f98107f9d8d7cc8e87a80874731422ab065ff3","b745d719629f63687ee7a43866ded654320d82a22726f2c96f7388cee2b888de","c03ee0786605973f9df85fa4a25a61646f4cbb9d174604a56b70dbc0f4017a73","c05a5b5b14245fa0ec140203662cf94cb07b84d37a0b27b973483cbe0a738553","c0b0d04b0709c32e3a4d540b62b00424d356b0129bf0c1764c210eb75303710d","c577d56af910f55b3a25d21e94b9ba404211935f3c2cecae9776bcc00459b8fe","c8063292070cf3c208764a86927a3d626d86230f729f35d69bcafbc93dbaea1f","cbd6fe879002646f5b96e7d365c5fee611bc8d0299fd7daabd1357846c67639a","d4d676af041b0802c7d11d015502d765a4056962bb870e5b4945576bfbee21cf","de21588dc0fef9be2c4bb78367d97968b0a114cdf6b57bd784b76fd7c1ba46e1","f6eb02423125bae89e652147fd4b1d6222198a10713a3539c63bce124f2e8205","fd339260da91cd1e25b2a9e8b144a008361fae3e612ea3bfa69adb1e1578d354","ff2bea6f3b1b36f7b7f480043157a0d3507648e80cdac252872442e3def757d7"],"recordQualifiers":{"310b501f770675d41a3cd7bbe4b36ee539d6115926db0a1896ef834d27625b04":"Onset group unspecified","313421fa839df22dae3779446458bc366d684796c2f2e160ffff54a810d42ab2":"Onset group unspecified","476330ebf193412bb6189c2b2ed80c2bdcb5a03b5c12f21c6b2ee1041f91b20f":"Onset group unspecified","4b6645fb6b152c5175364345486e48b5750e462f419fc80318996ea91b085f04":"Onset group unspecified","52ddbd11d64b9e1176e5e25564c75cc0ee12693b08701cbb8b8e9ce353cd48ed":"Onset group unspecified","530b64596630920edb7ad1ff140bdc71dcf9125b4f7ae8095b3a1128c5ef2ee5":"Onset group unspecified","60105fdae3863de8e41a8be02df52a3fb928d3d2f462492bd28700c00b50f6d5":"Onset group unspecified","6686e6431761ed2e0ca7eadfd03b08a12cacf6784e7c626bc81c71b98477d7f5":"Onset group unspecified","986906ad549af6681c8bf736c4f98107f9d8d7cc8e87a80874731422ab065ff3":"Onset group unspecified","c03ee0786605973f9df85fa4a25a61646f4cbb9d174604a56b70dbc0f4017a73":"Onset group unspecified","c0b0d04b0709c32e3a4d540b62b00424d356b0129bf0c1764c210eb75303710d":"Onset group unspecified","c577d56af910f55b3a25d21e94b9ba404211935f3c2cecae9776bcc00459b8fe":"Onset group unspecified","c8063292070cf3c208764a86927a3d626d86230f729f35d69bcafbc93dbaea1f":"Onset group unspecified","d4d676af041b0802c7d11d015502d765a4056962bb870e5b4945576bfbee21cf":"Onset group unspecified","de21588dc0fef9be2c4bb78367d97968b0a114cdf6b57bd784b76fd7c1ba46e1":"Onset group unspecified","f6eb02423125bae89e652147fd4b1d6222198a10713a3539c63bce124f2e8205":"Onset group unspecified","fd339260da91cd1e25b2a9e8b144a008361fae3e612ea3bfa69adb1e1578d354":"Onset group unspecified","ff2bea6f3b1b36f7b7f480043157a0d3507648e80cdac252872442e3def757d7":"Onset group unspecified"},"scopeLabel":"Genetic form","sourceIds":["OMIM:610127"],"sourceScope":null}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-f84c7caf535a7be3dae7"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0002104","HP:0001251","HP:0001272","HP:0002059","HP:0002074","HP:0001249","HP:0000369"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":19,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":27,"sourceGroups":{"omim":8,"published":19}},"features":[{"hpoId":"HP:0002104","label":"Apnea","primary":true},{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0001272","label":"Cerebellar atrophy","primary":true},{"hpoId":"HP:0002059","label":"Cerebral atrophy","primary":true},{"hpoId":"HP:0002074","label":"Increased neuronal autofluorescent lipopigment","primary":true},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":true},{"hpoId":"HP:0000369","label":"Low-set ears","primary":true},{"hpoId":"HP:0001268","label":"Mental deterioration","primary":false},{"hpoId":"HP:0000252","label":"Microcephaly","primary":false},{"hpoId":"HP:0032794","label":"Myoclonic seizure","primary":false},{"hpoId":"HP:0002529","label":"Neuronal loss in central nervous system","primary":false},{"hpoId":"HP:0005458","label":"Premature closure of fontanelles","primary":false},{"hpoId":"HP:0002878","label":"Respiratory failure","primary":false},{"hpoId":"HP:0002093","label":"Respiratory insufficiency","primary":false},{"hpoId":"HP:0001105","label":"Retinal atrophy","primary":false},{"hpoId":"HP:0002063","label":"Rigidity","primary":false},{"hpoId":"HP:0000510","label":"Rod-cone dystrophy","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0003390","label":"Sensory axonal neuropathy","primary":false},{"hpoId":"HP:0010864","label":"Severe intellectual disability","primary":false},{"hpoId":"HP:0000340","label":"Sloping forehead","primary":false},{"hpoId":"HP:0001257","label":"Spasticity","primary":false},{"hpoId":"HP:0001171","label":"Split hand","primary":false},{"hpoId":"HP:0002133","label":"Status epilepticus","primary":false},{"hpoId":"HP:0003657","label":"Vascular granular osmiophilic material deposition","primary":false},{"hpoId":"HP:0000572","label":"Visual loss","primary":false},{"hpoId":"HP:0000431","label":"Wide nasal bridge","primary":false}],"ledeHtml":"CLN10 disease is a severe disorder that primarily affects the nervous system. Individuals with this condition typically show signs and symptoms soon after birth. These signs and symptoms can include muscle rigidity, respiratory failure, and prolonged episodes of seizure activity that last several minutes (status epilepticus). It is likely that some affected individuals also have seizures before birth while in the womb. Infants with CLN10 disease have unusually small heads (microcephaly) with brains that may be less than half the normal size. There is a loss of brain cells in areas that coordinate movement (the cerebellum) and control thinking and emotions (the cerebral cortex). Nerve cells in the brain also lack a fatty substance called myelin, which protects them and promotes efficient transmission of nerve impulses. Infants with CLN10 disease often die hours to weeks after birth.","mondoId":"MONDO:0012414","node":{"canonicalSlug":"neuronal-ceroid-lipofuscinosis-10","comparisons":[{"documentSha256":"feab7132c1e6efa19316faa9c5b975a6a6317da700f12b5b4c059a18eda6d069","key":"legacy-cln","kind":"legacy","label":"CLN / Batten disease","memberIds":["MONDO:0008083","MONDO:0008767","MONDO:0008768","MONDO:0008769","MONDO:0009744","MONDO:0009745","MONDO:0010830","MONDO:0011144","MONDO:0012391","MONDO:0012414","MONDO:0012588","MONDO:0012721","MONDO:0013866","MONDO:0014147","MONDO:0016295"],"mondoId":"MONDO:0016295","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/cln.feab7132c1e6efa19316faa9c5b975a6a6317da700f12b5b4c059a18eda6d069.json"},{"documentSha256":"df7e5010cb40de30aba1b0d10ff00b9c8a49865234f6a0ea186c9a1493e9aae3","key":"expanded-cln","kind":"expanded","label":"CLN / Batten disease","memberIds":["MONDO:0008083","MONDO:0008767","MONDO:0008768","MONDO:0008769","MONDO:0009744","MONDO:0009745","MONDO:0010830","MONDO:0011144","MONDO:0012188","MONDO:0012391","MONDO:0012414","MONDO:0012588","MONDO:0012721","MONDO:0013866","MONDO:0014147","MONDO:0016295","MONDO:0017809","MONDO:0019260","MONDO:0019261","MONDO:0019262","MONDO:0030947","MONDO:0850001"],"mondoId":"MONDO:0016295","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-df7e5010cb40de30aba1.df7e5010cb40de30aba1b0d10ff00b9c8a49865234f6a0ea186c9a1493e9aae3.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":["Mutations in the CTSD gene cause CLN10 disease. The CTSD gene provides instructions for making an enzyme called cathepsin D. Cathepsin D is one of a family of cathepsin proteins that act as protease enzymes, which modify proteins by cutting them apart. Cathepsin D is found in many types of cells and is active in lysosomes, which are compartments within cells that digest and recycle different types of molecules. By cutting proteins apart, cathepsin D can break down certain proteins, turn on (activate) other proteins, and regulate self-destruction of the cell (apoptosis).","CTSD gene mutations found to cause CLN10 disease that is present at birth lead to a complete lack of cathepsin D enzyme activity. As a result, proteins and fats are not broken down properly and abnormally accumulate within lysosomes. While accumulations of these substances occurs in cells throughout the body, nerve cells appear to be particularly vulnerable to damage caused by the abnormal cell materials. Early and widespread loss of nerve cells in CLN10 disease leads to severe signs and symptoms and death in infancy.","In the later-onset cases of CLN10 disease, CTSD gene mutations likely result in the production of a cathepsin D enzyme whose function is greatly reduced but not eliminated. As a result, some proteins and fats are broken down by the enzyme, so it takes longer for these substances to accumulate in lysosomes and cause nerve cell death."],"causesUrl":"https://medlineplus.gov/genetics/condition/cln10-disease/#causes","contentForm":"summary","matchMethod":"reviewed-binding","name":"CLN10 disease","paragraphs":["CLN10 disease is a severe disorder that primarily affects the nervous system. Individuals with this condition typically show signs and symptoms soon after birth. These signs and symptoms can include muscle rigidity, respiratory failure, and prolonged episodes of seizure activity that last several minutes (status epilepticus). It is likely that some affected individuals also have seizures before birth while in the womb. Infants with CLN10 disease have unusually small heads (microcephaly) with brains that may be less than half the normal size. There is a loss of brain cells in areas that coordinate movement (the cerebellum) and control thinking and emotions (the cerebral cortex). Nerve cells in the brain also lack a fatty substance called myelin, which protects them and promotes efficient transmission of nerve impulses. Infants with CLN10 disease often die hours to weeks after birth.","In some individuals with CLN10 disease, the condition does not appear until later in life, between late infancy and adulthood. These individuals have a gradual loss of brain cells and often develop problems with balance and coordination (ataxia), loss of speech, a progressive loss in intellectual functioning (cognitive decline), and vision loss. Individuals with later-onset CLN10 disease have a shortened lifespan, depending on when their signs and symptoms first started.","CLN10 disease is one of a group of disorders known as neuronal ceroid lipofuscinoses (NCLs). All of these disorders affect the nervous system and typically cause progressive problems with vision, movement, and thinking ability. The different NCLs are distinguished by their genetic cause. Each disease type is given the designation \"CLN,\" meaning ceroid lipofuscinosis, neuronal, and then a number to indicate its subtype."],"reviewed":"2016-10","scope":"exact","scopeNote":"","source":"MedlinePlus","sourceRelease":"2026-10-01","upstream":"MedlinePlus Genetics","url":"https://medlineplus.gov/genetics/condition/cln10-disease"},"ownColumnKeys":["population-f84c7caf535a7be3dae7"],"publication":"published","relationships":[{"kind":"parent","label":"neuronal ceroid lipofuscinosis","mondoId":"MONDO:0016295","slug":"cln"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"native-cross-reference-does-not-establish-scope","source":"MedlinePlus","url":"https://medlineplus.gov/genetics/condition/cln10-disease"}],"translation":"pending","articles":[{"articleId":"rarediseases.info.nih.gov/diseases/1218","pageMondoId":"MONDO:0012414","source":"GARD","name":"Neuronal ceroid lipofuscinosis 10","url":"https://rarediseases.info.nih.gov/diseases/1218","relationToPage":"same-condition","coveredMondoIds":["MONDO:0012414"],"status":"validated-exact-source","presentation":"additional-reference","evidence":["existing-offline-scope-validator","automatic-identity-and-attribution"],"reviewed":null,"sourceRelease":"2026-10-25T03:38:27Z","upstream":"GARD:0001218","rawAttribution":"MONDO:0012414","independentCorroborationEstablished":false}]},"records":[{"frequencyKind":"reported","key":"0a41ab21ec49151348a41d69ed07aaa57b701ec0c1d494f6495c8dcfbfc19126","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002074","is_excluded":false,"label":"Increased neuronal autofluorescent lipopigment","onset_id":null,"reference":"OMIM:610127","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"0c4410c90ce4fa0b2b0a35c29463863e1b601f47468349ea3bda02df58a95f3a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"PCS","frequency_raw":"1/4","hpo_id":"HP:0032794","is_excluded":false,"label":"Myoclonic seizure","onset_id":"HP:0011461","reference":"PMID:16670177","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"310b501f770675d41a3cd7bbe4b36ee539d6115926db0a1896ef834d27625b04","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"PCS","frequency_raw":"1/4","hpo_id":"HP:0002878","is_excluded":false,"label":"Respiratory failure","onset_id":null,"reference":"PMID:16670177","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"313421fa839df22dae3779446458bc366d684796c2f2e160ffff54a810d42ab2","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"PCS","frequency_raw":"3/4","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"PMID:16670177","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"3cbfc0db37c239d51cc68ec6006dbcb714eb9e1311b8428b4ce9f53c2a1a1160","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"OMIM:610127","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"476330ebf193412bb6189c2b2ed80c2bdcb5a03b5c12f21c6b2ee1041f91b20f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"PCS","frequency_raw":"3/4","hpo_id":"HP:0000252","is_excluded":false,"label":"Microcephaly","onset_id":null,"reference":"PMID:16670177","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"4b6645fb6b152c5175364345486e48b5750e462f419fc80318996ea91b085f04","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:0002104","is_excluded":false,"label":"Apnea","onset_id":null,"reference":"PMID:16670177","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"52ddbd11d64b9e1176e5e25564c75cc0ee12693b08701cbb8b8e9ce353cd48ed","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"PCS","frequency_raw":"2/5","hpo_id":"HP:0003390","is_excluded":false,"label":"Sensory axonal neuropathy","onset_id":null,"reference":"PMID:25298308","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"530b64596630920edb7ad1ff140bdc71dcf9125b4f7ae8095b3a1128c5ef2ee5","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"PCS","frequency_raw":"1/4","hpo_id":"HP:0000340","is_excluded":false,"label":"Sloping forehead","onset_id":null,"reference":"PMID:16670177","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"60105fdae3863de8e41a8be02df52a3fb928d3d2f462492bd28700c00b50f6d5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"PCS","frequency_raw":"6/6","hpo_id":"HP:0001272","is_excluded":false,"label":"Cerebellar atrophy","onset_id":null,"reference":"PMID:25298308;PMID:16685649","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"6686e6431761ed2e0ca7eadfd03b08a12cacf6784e7c626bc81c71b98477d7f5","raw":{"aspect":"P","body_system":"ear","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"PCS","frequency_raw":"3/4","hpo_id":"HP:0000369","is_excluded":false,"label":"Low-set ears","onset_id":null,"reference":"PMID:16670177","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"70164ca550720bfde8067c77a6f875f29c41d509c40fe098a906e28f260b3b55","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000572","is_excluded":false,"label":"Visual loss","onset_id":null,"reference":"OMIM:610127","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"829e3794ae178617929bce4af09766aaa099d50f20e1da7651f7222f1e43659e","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002063","is_excluded":false,"label":"Rigidity","onset_id":null,"reference":"OMIM:610127","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"8475c4a36341652035a16ef41e8d09803459c9eb4e9fea843886eedfd8504126","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0005458","is_excluded":false,"label":"Premature closure of fontanelles","onset_id":null,"reference":"OMIM:610127","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"986906ad549af6681c8bf736c4f98107f9d8d7cc8e87a80874731422ab065ff3","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"PCS","frequency_raw":"3/4","hpo_id":"HP:0001257","is_excluded":false,"label":"Spasticity","onset_id":null,"reference":"PMID:16670177","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"b745d719629f63687ee7a43866ded654320d82a22726f2c96f7388cee2b888de","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002529","is_excluded":false,"label":"Neuronal loss in central nervous system","onset_id":null,"reference":"OMIM:610127","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"c03ee0786605973f9df85fa4a25a61646f4cbb9d174604a56b70dbc0f4017a73","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0010864","is_excluded":false,"label":"Severe intellectual disability","onset_id":null,"reference":"PMID:16685649","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"c05a5b5b14245fa0ec140203662cf94cb07b84d37a0b27b973483cbe0a738553","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002133","is_excluded":false,"label":"Status epilepticus","onset_id":null,"reference":"OMIM:610127","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"c0b0d04b0709c32e3a4d540b62b00424d356b0129bf0c1764c210eb75303710d","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"PCS","frequency_raw":"1/4","hpo_id":"HP:0000431","is_excluded":false,"label":"Wide nasal bridge","onset_id":null,"reference":"PMID:16670177","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c577d56af910f55b3a25d21e94b9ba404211935f3c2cecae9776bcc00459b8fe","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0002059","is_excluded":false,"label":"Cerebral atrophy","onset_id":null,"reference":"PMID:16685649","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c8063292070cf3c208764a86927a3d626d86230f729f35d69bcafbc93dbaea1f","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001105","is_excluded":false,"label":"Retinal atrophy","onset_id":null,"reference":"PMID:16685649","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"cbd6fe879002646f5b96e7d365c5fee611bc8d0299fd7daabd1357846c67639a","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002093","is_excluded":false,"label":"Respiratory insufficiency","onset_id":null,"reference":"OMIM:610127","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"d4d676af041b0802c7d11d015502d765a4056962bb870e5b4945576bfbee21cf","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"PCS","frequency_raw":"6/6","hpo_id":"HP:0001268","is_excluded":false,"label":"Mental deterioration","onset_id":null,"reference":"PMID:25298308;PMID:16685649","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"de21588dc0fef9be2c4bb78367d97968b0a114cdf6b57bd784b76fd7c1ba46e1","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"PCS","frequency_raw":"2/5","hpo_id":"HP:0003657","is_excluded":false,"label":"Vascular granular osmiophilic material deposition","onset_id":null,"reference":"PMID:25298308","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f6eb02423125bae89e652147fd4b1d6222198a10713a3539c63bce124f2e8205","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"PCS","frequency_raw":"1/4","hpo_id":"HP:0001171","is_excluded":false,"label":"Split hand","onset_id":null,"reference":"PMID:16670177","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"fd339260da91cd1e25b2a9e8b144a008361fae3e612ea3bfa69adb1e1578d354","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0000510","is_excluded":false,"label":"Rod-cone dystrophy","onset_id":null,"reference":"PMID:25298308","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ff2bea6f3b1b36f7b7f480043157a0d3507648e80cdac252872442e3def757d7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610127","disease_name":"Ceroid lipofuscinosis, neuronal, 10","evidence":"PCS","frequency_raw":"6/6","hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"PMID:25298308;PMID:16685649","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/cln10-disease\" rel=\"noreferrer\">MedlinePlus</a></p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/1218\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0012414\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>reviewed-binding</dd><dt>Upstream attribution</dt><dd>MedlinePlus Genetics</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>CLN10 disease is a severe disorder that primarily affects the nervous system. Individuals with this condition typically show signs and symptoms soon after birth. These signs and symptoms can include muscle rigidity, respiratory failure, and prolonged episodes of seizure activity that last several minutes (status epilepticus). It is likely that some affected individuals also have seizures before birth while in the womb. Infants with CLN10 disease have unusually small heads (microcephaly) with brains that may be less than half the normal size. There is a loss of brain cells in areas that coordinate movement (the cerebellum) and control thinking and emotions (the cerebral cortex). Nerve cells in the brain also lack a fatty substance called myelin, which protects them and promotes efficient transmission of nerve impulses. Infants with CLN10 disease often die hours to weeks after birth.</p><p>In some individuals with CLN10 disease, the condition does not appear until later in life, between late infancy and adulthood. These individuals have a gradual loss of brain cells and often develop problems with balance and coordination (ataxia), loss of speech, a progressive loss in intellectual functioning (cognitive decline), and vision loss. Individuals with later-onset CLN10 disease have a shortened lifespan, depending on when their signs and symptoms first started.</p><p>CLN10 disease is one of a group of disorders known as neuronal ceroid lipofuscinoses (NCLs). All of these disorders affect the nervous system and typically cause progressive problems with vision, movement, and thinking ability. The different NCLs are distinguished by their genetic cause. Each disease type is given the designation &quot;CLN,&quot; meaning ceroid lipofuscinosis, neuronal, and then a number to indicate its subtype.</p><p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/cln10-disease\" rel=\"noreferrer\">MedlinePlus</a></p>","key":"overview","title":"Overview"},{"bodyHtml":"<p>Mutations in the CTSD gene cause CLN10 disease. The CTSD gene provides instructions for making an enzyme called cathepsin D. Cathepsin D is one of a family of cathepsin proteins that act as protease enzymes, which modify proteins by cutting them apart. Cathepsin D is found in many types of cells and is active in lysosomes, which are compartments within cells that digest and recycle different types of molecules. By cutting proteins apart, cathepsin D can break down certain proteins, turn on (activate) other proteins, and regulate self-destruction of the cell (apoptosis).</p><p>CTSD gene mutations found to cause CLN10 disease that is present at birth lead to a complete lack of cathepsin D enzyme activity. As a result, proteins and fats are not broken down properly and abnormally accumulate within lysosomes. While accumulations of these substances occurs in cells throughout the body, nerve cells appear to be particularly vulnerable to damage caused by the abnormal cell materials. Early and widespread loss of nerve cells in CLN10 disease leads to severe signs and symptoms and death in infancy.</p><p>In the later-onset cases of CLN10 disease, CTSD gene mutations likely result in the production of a cathepsin D enzyme whose function is greatly reduced but not eliminated. As a result, some proteins and fats are broken down by the enzyme, so it takes longer for these substances to accumulate in lysosomes and cause nerve cell death.</p><p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/cln10-disease/#causes\" rel=\"noreferrer\">MedlinePlus</a></p>","key":"causes","title":"Causes"}],"sharedSources":[],"slug":"neuronal-ceroid-lipofuscinosis-10","sourceDocuments":[{"name":"MedlinePlus: CLN10 disease","reviewed":"2016-10","source_release":"2026-10-01","url":"https://medlineplus.gov/genetics/condition/cln10-disease"},{"name":"GARD: Neuronal ceroid lipofuscinosis 10","reviewed":null,"source_release":"2026-10-25T03:38:27Z","url":"https://rarediseases.info.nih.gov/diseases/1218"},{"name":"MONDO: neuronal ceroid lipofuscinosis 10","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0012414"}],"sourceNote":"","synonyms":["ceroid lipofuscinosis neuronal Cathepsin D-deficient","ceroid lipofuscinosis, neuronal, 10","ceroid lipofuscinosis, neuronal, type 10","CLN10","CLN10 disease, adult (subtype)","CLN10 disease, congenital (subtype)","CLN10 disease, juvenile (subtype)","CLN10 disease, late infantile (subtype)","CLN10-NCL","CTSD neuronal ceroid lipofuscinosis","neuronal ceroid lipofuscinosis caused by mutation in CTSD","neuronal ceroid lipofuscinosis due to cathepsin D deficiency","neuronal ceroid lipofuscinosis type 10"],"takeawayHtml":"","title":"neuronal ceroid lipofuscinosis 10"},"schemaVersion":1}
